Shulman DeMeo Asset Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$317K Sell
6,042
-100
-2% -$5.29K 0.06% 111
2026
Q1
$339K Buy
+6,142
New +$333K 0.07% 97
2022
Q3
Sell
-8,611
Closed -$469K 132
2022
Q2
$469K Buy
8,611
+393
+5% +$21.7K 0.16% 63
2022
Q1
$447K Buy
8,218
+34
+0.4% +$1.85K 0.12% 81
2021
Q4
$451K Buy
+8,184
New +$426K 0.12% 78
2021
Q3
Sell
-7,832
Closed -$390K 102
2021
Q2
$390K Buy
7,832
+34
+0.4% +$1.63K 0.15% 43
2021
Q1
$348K Buy
7,798
+3
+0% +$136 0.09% 98
2020
Q4
$359K Buy
7,795
+73
+0.9% +$3.35K 0.1% 92
2020
Q3
$363K Sell
7,722
-245
-3% -$12.3K 0.12% 78
2020
Q2
$406K Sell
7,967
-446
-5% -$22.9K 0.16% 65
2020
Q1
$398K Sell
8,413
-553
-6% -$29.5K 0.19% 54
2019
Q4
$527K Sell
8,966
-216
-2% -$12K 0.18% 61
2019
Q3
$490K Buy
9,182
+24
+0.3% +$1.24K 0.16% 64
2019
Q2
$458K Buy
9,158
+30
+0.3% +$1.5K 0.17% 63
2019
Q1
$477K Buy
9,128
+26
+0.3% +$1.3K 0.18% 57
2018
Q4
$435K Buy
+9,102
New +$448K 0.24% 37

Other funds holding GSK